PL3494110T3 - Pochodne pirymidyny i ich zastosowanie w leczeniu zakażenia syncytialnym wirusem oddechowym lub zapobieganiu mu - Google Patents
Pochodne pirymidyny i ich zastosowanie w leczeniu zakażenia syncytialnym wirusem oddechowym lub zapobieganiu muInfo
- Publication number
- PL3494110T3 PL3494110T3 PL17752431T PL17752431T PL3494110T3 PL 3494110 T3 PL3494110 T3 PL 3494110T3 PL 17752431 T PL17752431 T PL 17752431T PL 17752431 T PL17752431 T PL 17752431T PL 3494110 T3 PL3494110 T3 PL 3494110T3
- Authority
- PL
- Poland
- Prior art keywords
- treating
- preventing
- virus infection
- respiratory syncytial
- syncytial virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201613475 | 2016-08-04 | ||
| EP17752431.1A EP3494110B1 (en) | 2016-08-04 | 2017-08-03 | Pyrimidine derivatives and their use in treating or preventing a respiratory syncytial virus infection |
| PCT/GB2017/052257 WO2018025043A1 (en) | 2016-08-04 | 2017-08-03 | Pyrimidine derivatives and their use in treating or preventing a respiratory syncytial virus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3494110T3 true PL3494110T3 (pl) | 2021-10-04 |
Family
ID=59631799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17752431T PL3494110T3 (pl) | 2016-08-04 | 2017-08-03 | Pochodne pirymidyny i ich zastosowanie w leczeniu zakażenia syncytialnym wirusem oddechowym lub zapobieganiu mu |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10603319B2 (pl) |
| EP (1) | EP3494110B1 (pl) |
| JP (1) | JP6944514B2 (pl) |
| CY (1) | CY1124204T1 (pl) |
| DK (1) | DK3494110T3 (pl) |
| ES (1) | ES2878058T3 (pl) |
| HR (1) | HRP20210900T1 (pl) |
| HU (1) | HUE054772T2 (pl) |
| LT (1) | LT3494110T (pl) |
| PL (1) | PL3494110T3 (pl) |
| PT (1) | PT3494110T (pl) |
| RS (1) | RS61963B1 (pl) |
| SI (1) | SI3494110T1 (pl) |
| WO (1) | WO2018025043A1 (pl) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5256668A (en) * | 1993-03-17 | 1993-10-26 | American Home Products Corporation | Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus |
| ES2264721T3 (es) | 2001-03-12 | 2007-01-16 | Novelis, Inc. | Metodo y aparato para texturizar una chapa fina o banda metalica. |
| US6919331B2 (en) | 2001-12-10 | 2005-07-19 | Bristol-Myers Squibb Company | Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| WO2010103306A1 (en) | 2009-03-10 | 2010-09-16 | Astrazeneca Uk Limited | Benzimidazole derivatives and their use as antivaral agents |
| US20130085133A1 (en) * | 2010-02-08 | 2013-04-04 | Sourthern Research Institute Office of Commercialization and Intellectual Prop. | Anti-viral treatment and assay to screenfor anti-viral agent |
| GB201119538D0 (en) | 2011-11-10 | 2011-12-21 | Viral Ltd | Pharmaceutical compounds |
| CN104903313B (zh) | 2012-10-16 | 2017-12-29 | 爱尔兰詹森科学公司 | Rsv抗病毒化合物 |
| JP2016518421A (ja) * | 2013-05-14 | 2016-06-23 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 呼吸器合胞体ウイルス感染症の処置および予防のためのアザ−オキソ−インドール |
| PT3081569T (pt) * | 2013-12-10 | 2019-12-30 | Shandong Danhong Pharmaceutical Co Ltd | Derivado de imidazole utilizado como agente antiviral e sua utilização na preparação do medicamento |
| CN103699113B (zh) | 2013-12-13 | 2017-02-22 | 中国北车集团大连机车车辆有限公司 | 内燃机车控制器自检测电路及方法 |
| GB201411581D0 (en) | 2014-06-30 | 2014-08-13 | Inst Europ Di Oncologia S R L | Compounds inhibiting the enzyme monopolar spindle 1 kinase, pharmaceutical compositions and uses thereof |
| GB201417707D0 (en) * | 2014-10-07 | 2014-11-19 | Viral Ltd | Pharmaceutical compounds |
-
2017
- 2017-08-03 JP JP2019506181A patent/JP6944514B2/ja active Active
- 2017-08-03 SI SI201730785T patent/SI3494110T1/sl unknown
- 2017-08-03 DK DK17752431.1T patent/DK3494110T3/da active
- 2017-08-03 PT PT177524311T patent/PT3494110T/pt unknown
- 2017-08-03 US US16/322,264 patent/US10603319B2/en not_active Expired - Fee Related
- 2017-08-03 WO PCT/GB2017/052257 patent/WO2018025043A1/en unknown
- 2017-08-03 RS RS20210693A patent/RS61963B1/sr unknown
- 2017-08-03 EP EP17752431.1A patent/EP3494110B1/en active Active
- 2017-08-03 HU HUE17752431A patent/HUE054772T2/hu unknown
- 2017-08-03 PL PL17752431T patent/PL3494110T3/pl unknown
- 2017-08-03 LT LTEP17752431.1T patent/LT3494110T/lt unknown
- 2017-08-03 ES ES17752431T patent/ES2878058T3/es active Active
-
2021
- 2021-06-07 HR HRP20210900TT patent/HRP20210900T1/hr unknown
- 2021-06-07 CY CY20211100493T patent/CY1124204T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK3494110T3 (da) | 2021-06-07 |
| ES2878058T3 (es) | 2021-11-18 |
| US10603319B2 (en) | 2020-03-31 |
| CY1124204T1 (el) | 2022-05-27 |
| RS61963B1 (sr) | 2021-07-30 |
| EP3494110B1 (en) | 2021-03-10 |
| US20190167683A1 (en) | 2019-06-06 |
| SI3494110T1 (sl) | 2021-12-31 |
| LT3494110T (lt) | 2021-07-12 |
| HUE054772T2 (hu) | 2021-09-28 |
| JP6944514B2 (ja) | 2021-10-06 |
| PT3494110T (pt) | 2021-06-03 |
| HRP20210900T1 (hr) | 2021-08-20 |
| EP3494110A1 (en) | 2019-06-12 |
| WO2018025043A1 (en) | 2018-02-08 |
| JP2019527704A (ja) | 2019-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1212686A1 (zh) | 嘧啶酮衍生物和它們用於治療、改善或預防病毒疾病的用途 | |
| IL246564A (en) | 3-aryl-1-heterocyclic-pyrazolo [4,3- d] pyrimidine derivatives and their use in the treatment of diseases | |
| ZA201705633B (en) | A new quinoline derivative for use in the treatment and prevention of viral infections | |
| ZA201705634B (en) | Quinoline derivatives for use in the treatment or prevention of viral infection | |
| HK1212688A1 (zh) | 吡啶酮衍生物及其在治療、改善或預防病毒疾病中的用途 | |
| DK3681857T3 (en) | Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia | |
| SG11201702766YA (en) | Spiro-indolines for the treatment and prophylaxis of respiratory syncytial virus infection (rsv) | |
| PL3463469T3 (pl) | Kombinacja ledipaswiru i sofosbuwiru do zastosowania w leczeniu zakażeń wirusem zapalenia wątroby typu b u ludzi | |
| HK1258093A1 (zh) | 病毒新表位及其用途 | |
| HK1211288A1 (en) | Naphthyridinone derivatives and their use in the treatment,amelioration or prevention of a viral disease | |
| IL253878A0 (en) | An effective substance for the treatment of respiratory inflammation | |
| LT3494110T (lt) | Pirimidino dariniai ir jų panaudojimas respiracinių sincitinių virusų infekcijos gydymui arba prevencijai | |
| EP3345916A4 (en) | Compound for treating respiratory syncytial virus infection and preparation method and use thereof |